cover image - Psoriasis, 1st Edition
ISBN: 9780443434235
Copyright: 2028
Page Count: 368
Imprint: Elsevier
List Price: $169.99

Psoriasis, 1st Edition

by Joel M. Gelfand, MD, MSCE, FAAD

Paperback

cover image - Psoriasis, 1st Edition
ISBN: 9780443434235
Copyright: 2028
Page Count: 368
Imprint: Elsevier
List Price: $169.99

$169.99

Free Shipping!
Not Yet Available
Coming Soon!
Expected availability date: 03-29-2027
Offering a solid foundation of current knowledge on psoriasis as well as an up-to-date discussion of recent advancements in treatment research and new drug approvals, Psoriasis: An Expert Global Perspective is a one-stop reference for clinicians, researchers, and policy makers who seek a definitive, comprehensive resource in this fast-moving field. Developed in collaboration with and supported by the International Psoriasis Council, whose members are leading clinicians and researchers specializing in psoriasis, this first-of-its-kind text offers unparalleled global expertise on this chronic inflammatory disease. Readers will develop a thorough understanding of psoriasis’s complex clinical presentations, subtypes, and associated comorbidities—exactly the knowledge needed to help patients make informed choices about their treatments so they can live longer, healthier lives free of the burden of psoriatic disease.
    • Takes a multidisciplinary approach to this complex topic, covering immunology, genetics, epidemiology, and psychosocial aspects
    • Guides treatment across diverse settings: from resource-rich to resource-limited environments, covering topical, systemic, biologic, and alternative therapies
    • Includes numerous images of psoriasis sub-types shown in patients across the globe with different skin types
    • Recognizes the lived experience of patients, providing insights into long-term management and holistic care
    • Enhances patient care by translating complex research into practical clinical guidance
    • Provides up-to-date coverage of emerging treatments and research, from novel biologics, oral agents, and investigational therapies to artificial intelligence and future developments in the field
    • An eBook version is included with purchase. The eBook allows you to access all of the text, figures, and references, with the ability to search, make notes and highlights, and have content read aloud. Additional digital ancillary content may publish after the publication date
  • Section 1: Overview of Psoriasis: History, epidemiology, and Immunogentic Etiology
    1. Historical considerations about psoriasis
    2. Global epidemiology and burden of psoriasis
    3. Genetics of psoriasis
    4. Pathophysiology of psoriasis

    Section 2: Clinical Evaluation of Psoriasis
    5. Clinical Presentation and Assessment of Psoriasis and High Impact Sites
    6. Subtypes of Psoriasis (Erythrodermic, Guttate and Pustular Psoriasis)
    7. Nails
    8. Assessing health related quality of life in psoriasis

    Section 3: Treatment of Psoriasis and its Subtypes
    9. Vehicles for Topical Therapy
    10. Topical medications
    11. Ultraviolet approaches
    12. Old Oral Remedies for Psoriasis
    13. Traditional Medications including Methotrexate, Retinoids, and Cyclosporine
    14. Newer Oral Medications (apremilast, Deucravacitinib and other JAKi)
    15. Biologics (including biosimilars)
    16. Lifestyle Management (Herbs, Acupuncture, etc)

    Section 4: Special Populations
    17. Special Populations and Psoriasis: Pediatric Patients
    18. Special Populations and Psoriasis: Women
    19. Special Populations and Psoriasis: Older Adults

    Section 5: Comorbidity
    20. Psoriatic arthritis
    21. Obesity and Insulin Resistance
    22. Psoriasis and cardiovascular disease
    23. Psoriasis and Psychiatric Comorbidity
    24. Gastrointestinal Comorbidities in Psoriasis (Excluding Hepatic Disease): IBD and Non‑IBD Conditions
    25. Hepatic and Renal Comorbidities in Psoriasis
    26. Psoriasis and Malignancy

    Section 6: The Future
    27. Investigational Treatments for Psoriasis
    28. Artificial Intelligence in Psoriasis
    29. Teledermatology
    30. Role of Patient Advocacy and Contemporary Portrayal of Psoriasis in the Media
  • Joel M. Gelfand, MD, MSCE, FAAD, James J. Leyden Professor of Dermatology and of Epidemiology (with tenure); Director, Center for Clinical Sciences in Dermatology; Director, Psoriasis and Phototherapy Treatment Center, University of Pennsylvania Perelman School of Medicine; Member, Board of Directors and Treasurer, International Psoriasis Council, USA
  • No accessibility information is available for this product.

$169.99

Free Shipping!
Not Yet Available
Coming Soon!
Expected availability date: 03-29-2027